Wait, CNN Was Partying With the Iranians in the UK?
Why a Member of Jasmine Crockett's Security Team Was Just Shot and Killed...
Wait, Did This CNN Guest Just Blame the US for the 9/11 Attacks?
This Quote From Gov. Stitt Is NOT Good News Regarding Who He'd Pick...
What These Two Girls Are Laughing About Is Beyond Chilling
A Dissent for the Ages
Progressive Crackpots Vs. Environmental Wackos
The Congressman the Left Hates the Most Just Announced a Major Immigration Reform...
The Road to Tehran Runs Through Baku
The Parent-Led Rebellion Against EdTech
It’s Time to Build America With U.S.-Made Materials
DEI Is Dead. Corporate America Just Hasn’t Admitted It Yet.
Affordability Is Not a Slogan. Democrats Treat It Like One.
From Panic to Therapy: Cycle of Faux Climate Fear
President Donald J. Trump Can Index Capital Gains With Pen
Tipsheet

Despite Breakthrough Avoid BMY

Despite Breakthrough Avoid BMY

Welcome to John Ransom’s Stocks in the News where the headlines meet the trendlines.

Click here to listen to Ransom Notes Radio live or for archives of previous shows.

Advertisement

Stock number one: Apple Inc.

Apple still world’s top tablet seller: IDC-- MarketWatch

Apple Inc. remained the top seller of tablet computers during the third quarter, as research firm IDC said Thursday that world-wide shipments grew from a year ago due in large part to back-to-school season promotions and increased demand in the U.S.

The IDC report said third-quarter shipments rose 11.5% to 53.8 million units world-wide. IDC also said shipments rose 11.2% over the second quarter of the year. IDC analyst Phillippe Bouchard said that factors such as demand for connected tablets — or, tablets that can access the Internet via wireless networks without using Wi-Fi — are pushing sales of tablets higher across the board, and especially in the U.S.

Symbol: AAPL

Trailing PE: 17; Forward PE: 13

PEG: 1.21

Dividend: 1.80%

Estimate Trend: Up

Ransom Note Trendline: Hold Apple

Stock number two: Bristol-Myers Squibb Company

Bristol-Myers Lung-Cancer Drug Boosts Survival--IBD.com

Big pharma Bristol-Myers Squibb (NYSE:BMY) reported good midstage trial results for its drug candidate Opdivo in advanced squamous-cell lung cancer, sending its stock up nearly 8% to a 13-year high in early trading in the stock market today.

Advertisement

The patients in the trial were especially sick, as their illness had advanced despite at least two previous treatments. A year after the treatment, 41% were still alive, with the median survival rate at 8.2 months.

Symbol: BMY

Trailing PE: 36; Forward PE: 33

PEG: 3.07

Dividend: 2.70%

Estimate Trend: Up

Ransom Note Trendline: Avoid Bristol Meyers

Stock number three: Weight Watchers International, Inc

Why Weight Watchers’ Stock is Losing Weight-- Barron's

Weight Watchers’ (WTW) shares are shedding some weight of their own today despite solid earnings after the company raised concerns about spending during in 2015.

Weight Watchers reported a profit of 67 cents a share, beating forecasts for 48 cents, on sales of $345.2 million, ahead of consensus estimates for $337.52 million. Weight Watchers also boosted its full-year guidance to a range of $1.95 to $2.05, ahead of the Street’s $1.87 forecast.

Symbol: WTW

Trailing PE: 8; Forward PE: 17

PEG: -0.57

Dividend: NA

Estimate Trend: NA

Ransom Note Trendline: Sell Weight Watchers


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement